Encompass Health Corp (EHC) PT Raised to $130 at Mizuho

Mizuho analyst Ann Hynes raised the price target on Encompass Health Corp (NYSE: EHC) to $130.00 (from $110.00) while maintaining a Outperform rating.

The analyst commented: "We are increasing our price target to $130 (from $110), and raising our 2025E-2027E adjusted EBITDA estimates. EHC reported strong Q1:25 results with adjusted EBITDA beating consensus estimates by +7.6%, in part driven by strong volume, solid expense management and a favorable payer mix. Our new estimates reflect the Q1:25 beat and EHC's updated 2025E adjusted EBITDA guidance (up +1.9% at the midpoint). The company's guidance does not include the continuation of the Q1:25 payer mix environment, which could prove conservative. As a result, we believe earnings visibility is high and there is likely more upside to estimates going forward. We reiterate our Outperform rating."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'